Description
| Product Name | CAT.No | Size |
| Covid-19 Total Antibody | BXE0882A | 96T |
| COVID-19 IgM Antibody | BXE0883A | 96T |
| SARS-CoV-2 Neutralising Antibody (IgG) Antibody (Serum/Plasma) | BXE0885A | 96T |
Product Description
The Biorex Diagnostics COVID-19 Total Antibody ELISA kit is a quantitative microplate enzyme immunoassay (ELISA) designed for the accurate detection and measurement of total antibodies (IgG, IgM, and IgA) against SARS-CoV-2 in human serum or plasma. Total antibody detection provides a comprehensive view of the immune response, helping clinicians and researchers evaluate both natural infection and vaccination-induced immunity. Accurate measurement of these antibodies is critical for clinical diagnostics, monitoring vaccine efficacy, assessing population immunity, and supporting public health and epidemiological studies.
Key Features
- Comprehensive Antibody Detection – Simultaneously measures IgG, IgM, and IgA antibodies, allowing total antibody profiling in a single assay.
- High Sensitivity and Specificity – Minimises false positives and false negatives, ensuring confidence in clinical and research results.
- Quantitative Microplate ELISA – Provides precise and reproducible antibody measurements suitable for clinical and research applications.
- Sample Compatibility – Validated for use with human serum and plasma to support routine laboratory workflows.
- Ready-to-Use Kit – Includes pre-formulated reagents, calibrators, and controls to streamline testing and reduce preparation errors.
- ELISA Microplate Format – Colourimetric readout compatible with standard microplate readers, enabling high-throughput testing.
- Quality-Controlled – Guarantees consistency, reproducibility, and reliability across multiple laboratories and assay runs.
- Versatile Applications – Supports clinical diagnostics, vaccine monitoring, epidemiological studies, and immunological research.
The Biorex Diagnostics COVID-19 Total Antibody ELISA kit provides a trusted and efficient solution for assessing immune response to SARS-CoV-2. By enabling reliable detection of IgG, IgM, and IgA antibodies, the kit aids in early identification of prior exposure, evaluation of vaccination effectiveness, and monitoring of population immunity trends. Its robust design ensures reproducible results, standardised laboratory workflows, and suitability for high-throughput testing, making it a critical tool for clinical laboratories, research facilities, and public health monitoring programs worldwide. By providing precise and dependable antibody measurements, the assay supports informed clinical decision-making, epidemiological surveillance, and ongoing research into SARS-CoV-2 immunity and vaccine responses.
Contact Us for more information.